New Issue: Barclays sells $509,000 callable contingent coupon notes on Moderna

By Wendy Van Sickle

Columbus, Ohio, June 21 – Barclays Bank plc priced $509,000 of callable contingent coupon equity-linked notes due June 15, 2023 linked to the common stock of Moderna, Inc., according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 15% if the stock closes at or above its coupon trigger level, 65% of the initial price, on the determination date for that period.

The notes will be callable on any quarterly determination date after six months.

The payout at maturity will be par unless the stock finishes below its 65% trigger level, in which case investors will lose 1% for each 1% decline, payable as cash or shares at the issuer’s discretion.

Barclays is the agent.

Issuer:	Barclays Bank plc
Issue:	Callable contingent coupon equity-linked notes
Underlying stock:	Moderna, Inc.
Amount:	$509,000
Maturity:	June 15, 2023
Coupon:	15% per year, payable quarterly if shares close at or above coupon trigger level on a related determination date
Price:	Par
Payout at maturity:	Par unless the stock finishes below its trigger level, in which case investors will lose 1% for each 1% decline, payable as cash or shares at the issuer’s discretion
Call option:	At par on any quarterly determination date after six months
Initial share price:	$218.85
Coupon trigger level:	$142.25; 65% of initial share price
Trigger level:	$142.25; 65% of initial share price
Pricing date:	June 11
Settlement date:	June 17
Agent:	Barclays
Fees:	1.75%
Cusip:	06741WWB2

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.